The Discovery of Pamapimod and R1487 as Orally Bioavailable and Highly Selective Inhibitors of p38 Map Kinase
Soth, M., Kuglstatter, A., Goldstein, D.To be published.
Experimental Data Snapshot
Starting Model: experimental
View more details
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Mitogen-activated protein kinase 14 | 372 | Homo sapiens | Mutation(s): 0 Gene Names: CSBP, CSBP1, CSBP2, CSPB1, MAPK14, MXI2 EC: 2.7.11.24 | ||
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for Q16539 (Homo sapiens) Explore Q16539 Go to UniProtKB: Q16539 | |||||
PHAROS: Q16539 GTEx: ENSG00000112062 | |||||
Entity Groups | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | Q16539 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
FMJ Query on FMJ | B [auth A] | 4-(5-methyl-3-phenylisoxazol-4-yl)pyrimidin-2-amine C14 H12 N4 O XWMBSXFOZPVNQH-UHFFFAOYSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 45.735 | α = 90 |
b = 85.699 | β = 90 |
c = 126.878 | γ = 90 |
Software Name | Purpose |
---|---|
REFMAC | refinement |
CNS | refinement |
ADSC | data collection |
DENZO | data reduction |
SCALEPACK | data scaling |
CNS | phasing |